about
Avalyn Pharma Inc is a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). Its current pipeline is focused on treating pul...
Read More
27.33
0.40
(1.49%)
290.4K
XNAS Volume
XNAS 08 May, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
No Score Avaliable
Avalyn Pharma Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..